Vaccines, Free Full-Text

To investigate early immune responses and explore the optimal vaccination periods, Nile tilapia at 1, 7, 14, 21, 28, 35, and 42 days after yolk sac collapse (DAYC) were immersed in formalin-killed Streptococcus agalactiae vaccine (FKV-SA). A specific IgM was first detected via ELISA in the 21 DAYC larvae (0.108 g) at 336 h after vaccination (hav), whereas in the 28–42 DAYC larvae (0.330–0.580 g), the specific IgM could be initially detected at 24 hav. qRT–PCR analysis of the TCRβ, CD4, MHCIIα, IgHM, IgHT, and IgHD genes in 21–42 DAYC larvae immunized with the FKV-SA immersion route for 24, 168, and 336 hav revealed that the levels of most immune-related genes were significantly higher in the vaccinated larvae at all DAYCs than in the control larvae (p < 0.05) at 336 hav. Immunohistochemistry demonstrated stronger IgM signals in the gills, head kidney, and intestine tissues at 21, 28, and 35 DAYC in all vaccinated larvae compared with the control. Interestingly, at all DAYCs, FKV-SA larvae exhibited significantly higher survival rates and an increased relative percent survival (RPS) than the control after challenge with viable S. agalactiae, particularly in larvae that were immunized with FKV-SA at 168 and 336 hav (p < 0.05).

Challenges in ensuring global access to COVID-19 vaccines

The world will soon have covid-19 vaccines. Will people have the jabs?

Respiratory mucosal delivery of next-generation COVID-19 vaccine

Full article: Social media and vaccine hesitancy: new updates for

4th COVID-19 Vaccine: When Omicron Bivalent Boosters Will Be Available

Protection against SARS-CoV-2 after Covid-19 Vaccination and

Frontiers Predictors of COVID-19 Vaccine Acceptance, Intention

Duration of effectiveness of vaccines against SARS-CoV-2 infection

Pittsburgh Regional Health Initiative Promotes 10 COVID-19 Vaccine

Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide

Info for Parents

Revisiting COVID-19 vaccine hesitancy around the world using data

COVID-19 Vaccine COVID-19 Vaccine

Influenza and COVID-19 Vaccination Coverage Among Health Care